Crisaborole
| CAS No. | 906673-24-3 |
|---|---|
| MDL No. | MFCD17169940 |
| MF | C14H10BNO3 |
| MW | 251.05 |
| InChI Key | USZAGAREISWJDP-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Crisaborole is a benzoxaborole compound, specifically 5-(4-cyanophenyl)-1,3-dihydro-2,1-benzoxaborole, where the phenolic hydrogen is replaced by a 4-cyanophenyl group. It is a phosphodiesterase 4 inhibitor used to treat mild to moderate atopic dermatitis in children and adults. It functions as a phosphodiesterase IV inhibitor, an antipsoriatic, and a non-steroidal anti-inflammatory drug. It is also classified as an aromatic ether and a nitrile.
| CAS No. | 906673-24-3 |
|---|---|
| Product Name | Crisaborole |
Biological Targets
PDE4A·PDE4D·PDE4B·PDE4C
Associated Conditions
psoriasis·dermatitis·atopic eczema·Vitiligo·localised scleroderma·
* The information provided here is compiled from public sources and is for reference only.